These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 1449012

  • 21. Osteopontin expression in normal and fibrotic liver. altered liver healing in osteopontin-deficient mice.
    Lorena D, Darby IA, Gadeau AP, Leen LL, Rittling S, Porto LC, Rosenbaum J, Desmoulière A.
    J Hepatol; 2006 Feb; 44(2):383-90. PubMed ID: 16221502
    [Abstract] [Full Text] [Related]

  • 22. Expression of extracellular matrix proteoglycans perlecan and decorin in carbon-tetrachloride-injured rat liver and in isolated liver cells.
    Gallai M, Kovalszky I, Knittel T, Neubauer K, Armbrust T, Ramadori G.
    Am J Pathol; 1996 May; 148(5):1463-71. PubMed ID: 8623917
    [Abstract] [Full Text] [Related]

  • 23. [The mechanism for splenic promoting effects on liver cirrhosis].
    Wang Q, Xia S, Jiang H.
    Zhonghua Yi Xue Za Zhi; 1995 Oct; 75(10):594-8, 638. PubMed ID: 8697073
    [Abstract] [Full Text] [Related]

  • 24. Immunolocalization of heparin-binding growth factors (HBGF) types 1 and 2 in rat liver. Selective hyperexpression of HBGF-2 in carbon tetrachloride-induced fibrosis.
    Charlotte F, Win KM, Preaux AM, Mavier P, Dhumeaux D, Zafrani ES, Rosenbaum J.
    J Pathol; 1993 Apr; 169(4):471-6. PubMed ID: 7684779
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Inhibition of plasminogen activator inhibitor-1 expression by siRNA in rat hepatic stellate cells.
    Hu PF, Zhu YW, Zhong W, Chen YX, Lin Y, Zhang X, Yin C, Yue HY, Xie WF.
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1917-25. PubMed ID: 18761555
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Lack of tumor necrosis factor receptor type 1 inhibits liver fibrosis induced by carbon tetrachloride in mice.
    Sudo K, Yamada Y, Moriwaki H, Saito K, Seishima M.
    Cytokine; 2005 Mar 07; 29(5):236-44. PubMed ID: 15760680
    [Abstract] [Full Text] [Related]

  • 29. Role of transforming growth factor beta type II receptor in hepatic fibrosis: studies of human chronic hepatitis C and experimental fibrosis in rats.
    Roulot D, Sevcsik AM, Coste T, Strosberg AD, Marullo S.
    Hepatology; 1999 Jun 07; 29(6):1730-8. PubMed ID: 10347115
    [Abstract] [Full Text] [Related]

  • 30. Coexpression of the collagen-binding stress protein HSP47 gene and the alpha 1(I) and alpha 1(III) collagen genes in carbon tetrachloride-induced rat liver fibrosis.
    Masuda H, Fukumoto M, Hirayoshi K, Nagata K.
    J Clin Invest; 1994 Dec 07; 94(6):2481-8. PubMed ID: 7989606
    [Abstract] [Full Text] [Related]

  • 31. Inhibition of hepatic damage and liver fibrosis by brain natriuretic peptide.
    Sonoyama T, Tamura N, Miyashita K, Park K, Oyamada N, Taura D, Inuzuka M, Fukunaga Y, Sone M, Nakao K.
    FEBS Lett; 2009 Jun 18; 583(12):2067-70. PubMed ID: 19463821
    [Abstract] [Full Text] [Related]

  • 32. Increase of hepatic mRNAS of profilin, actin and extracellular matrix proteins after carbon tetrachloride treatment and partial hepatectomy in rats.
    Nakamura H, Hirata K, Yamashiro K, Hiranuma K, Shibata K, Higashi K, Morita T, Hirano H.
    Biochem Biophys Res Commun; 1994 Jan 28; 198(2):568-73. PubMed ID: 8297366
    [Abstract] [Full Text] [Related]

  • 33. Up-regulation of type I procollagen C-proteinase enhancer protein messenger RNA in rats with CCl4-induced liver fibrosis.
    Ogata I, Auster AS, Matsui A, Greenwel P, Geerts A, D'Amico T, Fujiwara K, Kessler E, Rojkind M.
    Hepatology; 1997 Sep 28; 26(3):611-7. PubMed ID: 9303490
    [Abstract] [Full Text] [Related]

  • 34. The effects of hepatic fibrosis on Ito cell gene expression.
    Weiner FR, Shah A, Biempica L, Zern MA, Czaja MJ.
    Matrix; 1992 Feb 28; 12(1):36-43. PubMed ID: 1560788
    [Abstract] [Full Text] [Related]

  • 35. Gene-CYP11B2 expression in rat liver in hepatic fibrogenesis induced by CCl4.
    Li X, Yang X, Wu P, Meng Y, Li S, Lai W.
    Chin Med J (Engl); 2001 Jan 28; 114(1):64-8. PubMed ID: 11779439
    [Abstract] [Full Text] [Related]

  • 36. Conditional tetracycline-regulated expression of TGF-beta1 in liver of transgenic mice leads to reversible intermediary fibrosis.
    Ueberham E, Löw R, Ueberham U, Schönig K, Bujard H, Gebhardt R.
    Hepatology; 2003 May 28; 37(5):1067-78. PubMed ID: 12717387
    [Abstract] [Full Text] [Related]

  • 37. Experimental carbon tetrachloride-induced cirrhosis of the liver.
    Muñoz Torres E, Paz Bouza JI, Abad Hernandez MM, Alonso Martin MJ, Lopez Bravo A.
    Int J Tissue React; 1988 May 28; 10(4):245-51. PubMed ID: 3250938
    [Abstract] [Full Text] [Related]

  • 38. [The effect of D-penicillamine on experimental liver cirrhosis induced by CCl4].
    Schaff Z, Lapis K, Szende B, Jeney A, Gonzales Cabello R, Gergely P, Simon K, Divald A, Timár F, Major J.
    Morphol Igazsagugyi Orv Sz; 1990 Jul 28; 30(3):161-9. PubMed ID: 2233769
    [Abstract] [Full Text] [Related]

  • 39. Anti-fibrogenic function of angiotensin II type 2 receptor in CCl4-induced liver fibrosis.
    Nabeshima Y, Tazuma S, Kanno K, Hyogo H, Iwai M, Horiuchi M, Chayama K.
    Biochem Biophys Res Commun; 2006 Aug 04; 346(3):658-64. PubMed ID: 16774739
    [Abstract] [Full Text] [Related]

  • 40. Significance and therapeutic potential of endothelial progenitor cell transplantation in a cirrhotic liver rat model.
    Nakamura T, Torimura T, Sakamoto M, Hashimoto O, Taniguchi E, Inoue K, Sakata R, Kumashiro R, Murohara T, Ueno T, Sata M.
    Gastroenterology; 2007 Jul 04; 133(1):91-107.e1. PubMed ID: 17631135
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.